BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22231699)

  • 1. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
    Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
    J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.
    Stary G; Bangert C; Tauber M; Strohal R; Kopp T; Stingl G
    J Exp Med; 2007 Jun; 204(6):1441-51. PubMed ID: 17535975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
    Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
    PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
    Wu J; Li S; Yang Y; Zhu S; Zhang M; Qiao Y; Liu YJ; Chen J
    Oncotarget; 2017 Feb; 8(7):11708-11718. PubMed ID: 28052019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
    Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
    Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcriptional regulator NAB2 reveals a two-step induction of TRAIL in activated plasmacytoid DCs.
    Balzarolo M; Karrich JJ; Engels S; Blom B; Medema JP; Wolkers MC
    Eur J Immunol; 2012 Nov; 42(11):3019-27. PubMed ID: 22806638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG.
    Wu J; Li S; Li T; Lv X; Zhang M; Zang G; Qi C; Liu YJ; Xu L; Chen J
    J Immunol Res; 2019; 2019():1749803. PubMed ID: 31093508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.
    Gujer C; Sundling C; Seder RA; Karlsson Hedestam GB; Loré K
    Immunology; 2011 Nov; 134(3):257-69. PubMed ID: 21977996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.
    Drobits B; Holcmann M; Amberg N; Swiecki M; Grundtner R; Hammer M; Colonna M; Sibilia M
    J Clin Invest; 2012 Feb; 122(2):575-85. PubMed ID: 22251703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
    Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
    J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates.
    Poth JM; Coch C; Busch N; Boehm O; Schlee M; Janke M; Zillinger T; Schildgen O; Barchet W; Hartmann G
    J Immunol; 2010 Dec; 185(12):7367-73. PubMed ID: 21057083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.
    Dillmann C; Ringel C; Ringleb J; Mora J; Olesch C; Fink AF; Roberts E; Brüne B; Weigert A
    J Immunol; 2016 Feb; 196(4):1579-90. PubMed ID: 26783340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.
    Dominguez-Molina B; Machmach K; Perales C; Tarancon-Diez L; Gallego I; Sheldon JL; Leal M; Domingo E; Ruiz-Mateos E
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients.
    Stary G; Klein I; Kohlhofer S; Koszik F; Scherzer T; Müllauer L; Quendler H; Kohrgruber N; Stingl G
    Blood; 2009 Oct; 114(18):3854-63. PubMed ID: 19690337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation.
    Barblu L; Machmach K; Gras C; Delfraissy JF; Boufassa F; Leal M; Ruiz-Mateos E; Lambotte O; Herbeuval JP;
    J Infect Dis; 2012 Sep; 206(5):790-801. PubMed ID: 22693234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.